PureTech

PureTech is a clinical-stage biotherapeutics company based in Boston, Massachusetts. With a team of 107 employees, PureTech focuses on developing innovative medicines to address life-threatening diseases. The company generated $7 million in revenue in its last fiscal year. PureTech's mission is to bring novel therapies to market by leveraging its expertise in research and development. Their extensive network spans scientists, clinicians, and industry leaders, facilitating the advancement of therapeutic candidates both internally and through its Founded Entities. PureTech's R&D engine has yielded a robust pipeline of 29 therapeutics and candidates. Notably, two have received both U.S. FDA clearance and European marketing authorization, while a third (KarXT) is awaiting FDA approval. Multiple programs are currently undergoing clinical development, including key registration enabling studies. For more information about PureTech and its groundbreaking research, visit www.puretechhealth.com or follow them on X (formerly Twitter) @puretechh.